During its May 21 Analyst and Investor event, Micron technology, Inc. (MU) announced that its Board of Directors authorized a new share repurchase program. The company will be able to purchase up to $10 billion of its outstanding common stock. In addition, Micron announced plans to return up to 50% of free cash flow to […]
Read more...
Old Dominion Freight Line, Inc. (ODFL) announced on May 17 that the company’s Board of Directors authorized a new share repurchase program. Beginning after the May 23 expiration of the previous program, the repurchase program authorizes the repurchase of up to $250 million in common stock. In addition, Old Dominion Freight Line will pay a […]
Read more...
Avinger, Inc. reported on May 23 that the company has received 510(k) clearance from the FDA for its next-generation Pantheris Lumivascular atherectomy system. Lumivascular is the only technology that combines both real-time intravascular imaging with catheters to treat peripheral artery disease (PAD). This is the first image-guided atherectomy device for the treatment of PAD. Sonal […]
Read more...
On May 15, Global Medical, Inc. (GMED) reported the results of a medical study that supported the benefits of the company’s Globus expandable lateral spacers. The study “Clinical and radiographic analysis of expandable versus static lateral lumbar interbody fusion devices with two-year follow-up” was published in the Journal of Spine Surgery. Dr. Joseph O’Brien, MD, […]
Read more...
On May 11, Heartland Express, Inc. (HTLD) announced that the company’s Board of Directors approved a new share repurchase program. Under this program, the company can repurchase up to 5 million shares of outstanding common stock. This program is an addition to the 2.3 million shares previously authorized for repurchase by the Board of Directors. […]
Read more...
Lannett Company, Inc. (LCI) announced on May 21 that they have received FDA approval for Dronabinol Capsules. The drug is the therapeutic equivalent to Marinol Capsules, and only a handful of suppliers manufacture generic versions of the drug for the US market. Dronabinol Capsules can be used to treat patients with loss of appetite due […]
Read more...
On May 18, RXi Pharmaceuticals Corporation (RXII) reported positive results from its phase 2 clinical trial of the drug Samcyprone for the treatment of common warts. After weekly application for 10 weeks, participants had a 97.7% positive immunotherapy response rate. 70% of participants experienced a reduction of at least 50% wart size. There is currently […]
Read more...
Diana Shipping Inc. (DSI) announced on May 10 that the company has signed a time charter contract with Koch Shipping Pte. Ltd. Diana will charter the M/V San Francisco, a Newcastlemax dry bulk vessel that was built in 2018. This employment will take place over 10-12 months and is expected to generate approximately $6.96 million […]
Read more...
PennantPark Investment Corporation (PNNT) announced on May 9 that its Board of Directors approved a new share repurchase program. The program will allow the company to repurchase up to $30 million worth of outstanding common shares. The Board of Directors expects that this repurchase program will be in place until May 8, 2019. Sonal […]
Read more...
On May 3, Atlas Air Worldwide Holdings, Inc. (AAWW) announced that the company’s first-quarter volume and revenue increased by 20%. Encouraged by the strong first-quarter financial results, the company increased its annual earnings guidance. Atlas Air Worldwide now expects earnings growth to top 30% during the 2018 fiscal year. Sonal alerted its subscribers about […]
Read more...